摘要
本文报告了900例食管癌及贲门癌手术治疗效果。切除率76.8％,并发症率9.3％,死亡率3.8％。1、3、5、10年生存率分别为75.5％、34.2％、24.9％和9.5％。病变大小、淋巴结转移、分期及断端癌残留是影响5年生存率的主要因素。术后辅助放疗可改善断端病残留病例的预后。作者建议对此类病例宜补加术后放疗。同时对食管的合适切除长度及吻合口瘘的治疗进行了讨论。
Nine hundred patients with esophageal or cardiac carcinoma were treated by esophagogastrecromy with rates of resectability. morbidity and mortality being 76. 8%, 9. 3%and 3. 8% respectively. The 1, 3, 5 and 10 years sur- vival rates were 75. 5 %. 34. 2% . 24. 9%and9. 5% respectively. Prognostie influeneing factors included tumor size, lymph node metastases.stage and residual carcinoma in the cutting edges. Postoperative radiotherapy improved the survival of patients with residual carcinoma, therefore, it is recommended for such cases. The appropriate resection length of esoph- agus and the management of anastomotic leakage were discussed.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
1993年第9期693-695,共3页
Chinese Journal of Clinical Oncology
关键词
贲门肿瘤
癌
吻合口瘘
食管肿瘤
Esophageal carcinoma
Cardiac carcinoma
Surgical treatment
Residual carcinoma
